- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Annual Issues ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
Journal of Obesity
Volume 2011 (2011), Article ID 806896, 7 pages
Taking Orlistat: Predicting Weight Loss over 6 Months
Department of Psychology, University of Surrey, Guildford, Surrey GU2 7XH, UK
Received 23 September 2010; Accepted 11 October 2010
Academic Editor: A. Halpern
Copyright © 2011 Amelia Hollywood and Jane Ogden. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- National Institute for Clinical Excellence, “Guidance on the use of orlistat for the treatment of obesity in adults,” Technology Appraisal Guidance No.22, 2001.
- Royal College of Physicians of London, “Anti-obesity drugs: Guidance on appropriate prescribing and management,” A report of the Nutrition Committee of the Royal College of Physicians of London, 2003.
- J. Srishanmuganathan, H. Patel, J. Car, and A. Majeed, “National trends in the use and costs of anti-obesity medications in England 1998–2005,” Journal of Public Health, vol. 29, no. 2, pp. 199–202, 2007.
- R. Padwal, S. K. Li, and D. C. W. Lau, “Long-term pharmacotherapy for overweight and obesity: a systematic review and meta-analysis of randomized controlled trials,” International Journal of Obesity, vol. 27, no. 12, pp. 1437–1446, 2003.
- A. Avenell, T. J. Brown, M. A. McGee et al., “What interventions should we add to weight reducing diets in adults with obesity? A systematic review of randomized controlled trials of adding drug therapy, exercise, behaviour therapy or combinations of these interventions,” Journal of Human Nutrition and Dietetics, vol. 17, no. 4, pp. 293–316, 2004.
- S. Phelan and T. A. Wadden, “Combining behavioral and pharmacological treatments for obesity,” Obesity research, vol. 10, no. 6, pp. 560–574, 2002.
- D. Rucker, R. Padwal, S. K. Li, C. Curioni, and D. C. W. Lau, “Long term pharmacotherapy for obesity and overweight: updated meta-analysis,” British Medical Journal, vol. 335, no. 7631, pp. 1194–1199, 2007.
- M. Vray, J.-M. Joubert, E. Eschwège et al., “Results from the observational study EPIGRAM: management of excess weight in general practice and follow-up of patients treated with orlistat,” Therapie, vol. 60, no. 1, pp. 17–24, 2005.
- V. Hainer, M. Kunesova, F. Bellisle et al., “Psychobehavioral and nutritional predictors of weight loss in obese women treated with sibutramine,” International Journal of Obesity, vol. 29, no. 2, pp. 208–216, 2005.
- D. L. Hansen, A. Astrup, S. Toubro et al., “Predictors of weight loss and maintenance during 2 years of treatment by sibutramine in obesity. Results from the European multi-centre STORM trial,” International Journal of Obesity, vol. 25, no. 4, pp. 496–501, 2001.
- N. V. Dhurandhar, R. C. Blank, D. Schumacher, and R. L. Atkinson, “Initial weight loss as a predictor of response to obesity drugs,” International Journal of Obesity, vol. 23, no. 12, pp. 1333–1336, 1999.
- J. J. G. Martínez, F. A. Ruiz, and S. D. Candil, “Baseline serum folate level may be a predictive factor of weight loss in a morbid-obesity-management programme,” British Journal of Nutrition, vol. 96, no. 5, pp. 956–964, 2006.
- N. Finer, “Pharmacotherapy of obesity,” Best Practice and Research: Clinical Endocrinology and Metabolism, vol. 16, no. 4, pp. 717–742, 2002.
- J. Ogden and S. Sidhu, “Adherence, behavior change, and visualization: a qualitative study of the experiences of taking an obesity medication,” Journal of Psychosomatic Research, vol. 61, no. 4, pp. 545–552, 2006.
- J. Ogden, “The correlates of long-term weight loss: a group comparison study of obesity,” International Journal of Obesity, vol. 24, no. 8, pp. 1018–1025, 2000.
- J. Ogden, I. Bandara, H. Cohen et al., “General practitioners' and patients' models of obesity: whose problem is it?” Patient Education and Counseling, vol. 44, no. 3, pp. 227–233, 2001.
- H. Leventhal, M. Diefenbach, and E. A. Leventhal, “Illness cognition: using common sense to understand treatment adherence and affect cognition interactions,” Cognitive Therapy and Research, vol. 16, no. 2, pp. 143–163, 1992.
- J. Ogden and L. Hills, “Understanding sustained changes in behaviour: the role of life events and the process of reinvention,” Health, vol. 12, pp. 419–437, 2008.
- E. Broadbent, K. J. Petrie, J. Main, and J. Weinman, “The brief illness perception questionnaire,” Journal of Psychosomatic Research, vol. 60, no. 6, pp. 631–637, 2006.
- C. Currie, O. Samdal, W. Boyce, and B. Smith, Health Behaviour in School-Aged Children: A World Health Organisation Cross-National Study. Research Protocol for the 2001/2002 Survey, Child and adolescent health research unit. University of Edinburgh, Scotland, UK, 2001.
- J. Inchley, J. Todd, C. Bryce, and C. Currie, “Dietary trends among Scottish schoolchildren in the 1990s,” Journal of Human Nutrition and Dietetics, vol. 14, no. 3, pp. 207–216, 2001.
- J. Gregory, S. Lowe, C. J. Bates, et al., National Diet and Nutrition Survey: Young people aged 4-18 years vol 1: Report of the Diet and Nutrition Survey, The Stationary Office, London, UK, 2000.
- Mintel Market Intelligence Food and Drink, “Market Intelligence UK Market Intelligence Standard Children’s Snacking Habits,” UK, May 2003.